J Travel Med
January 2022
We establish the feasibility of evaluating US international travellers for acquisition using a culture-based screening protocol. was not identified in any of the travellers in this small cohort; further study is needed to determine the overall risk and risk factors for travel-associated acquisition.
View Article and Find Full Text PDF